Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a new version of the ClinicalTrials.gov record. This revision does not change the study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-29T23:40:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision bumped from v3.6.4 to v3.6.5, reflecting a minor page version update. It does not modify study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-08T23:44:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's version tag was updated from v3.6.3 to v3.6.4, signaling a minor platform update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T16:43:07.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the page version.
    Difference
    0.1%
    Check dated 2026-07-04T05:55:02.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated page version.
    Difference
    0.1%
    Check dated 2026-06-27T06:01:51.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participants are being sought, and new guidance sections were added to help users read the study record and join the study. The revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.6%
    Check dated 2026-06-13T01:31:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.